REGULATED PRESS RELEASE published on 07/07/2025 at 07:00, 8 months 16 days ago Obesity: Biophytis Charts Its Course Toward a Booming Market Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
BRIEF published on 07/03/2025 at 07:05, 8 months 20 days ago Biophytis Showcases Innovations at BIO International 2025 Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
BRIEF published on 07/03/2025 at 07:05, 8 months 20 days ago Biophytis : Avancées Thérapeutiques Présentées à la BIO International 2025 Biophytis Innovations Santé Thérapies Convention BIO 2025
REGULATED PRESS RELEASE published on 07/03/2025 at 07:00, 8 months 20 days ago Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025 Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact Innovations Longevity Obesity Muscle Health Biophy(s
REGULATED PRESS RELEASE published on 07/03/2025 at 07:00, 8 months 20 days ago Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025 BiophyHs SA présente ses avancées dans l'obésité, la sarcopénie et la longévité à la BIO Interna(onal 2025, soulignant ses thérapies innovantes et partenariats stratégiques pour le développement mondial Longévité Sarcopénie Obésité BiophyHs SA BIO InternaHonal 2025
PRESS RELEASE published on 07/03/2025 at 06:59, 8 months 20 days ago Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025 BiophyHs annonce son succès à la BIO International Convention 2025, présentant des avancées en obésité, sarcopénie et longévité, avec des partenariats stratégiques post-conférence Longévité Sarcopénie Obésité BIO International Convention 2025 BiophyHs
BRIEF published on 06/30/2025 at 22:35, 8 months 23 days ago Biophytis reporte la publication de ses comptes annuels Biophytis Biotechnologie Comptes Annuels Recherche Clinique Publication Retardée
BRIEF published on 06/30/2025 at 22:35, 8 months 23 days ago Biophytis Delays Publication of 2024 Annual Financial Statements Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE published on 06/30/2025 at 22:30, 8 months 23 days ago Information on the Annual Financial Statements Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
REGULATED PRESS RELEASE published on 06/30/2025 at 22:30, 8 months 23 days ago Information sur les comptes annuels Biophytis SA informe qu'elle n'est pas en mesure de publier ses comptes annuels 2024 à la date prévue mais les publiera au plus tard le 07 juillet 2025 Biophytis Développement Biotechnologie Comptes Annuels Maladies Liées À L'âge
Published on 03/23/2026 at 22:40, 6 hours 11 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 6 hours 21 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 6 hours 51 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 7 hours 33 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/24/2026 at 02:00, 2 hours 51 minutes ago Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 3 hours 56 minutes ago mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
Published on 03/24/2026 at 00:09, 4 hours 42 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 6 hours 46 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 7 hours 46 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 19:08, 9 hours 43 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 9 hours 43 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 10 hours 14 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 11 hours 6 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 11 hours 6 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde